Sunil Lakhwani

Santa Cruz De Tenerife, CN, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Early Use of Fostamatinib in Immune Thrombocytopenia.

Early Use of Fostamatinib in Immune Thrombocytopenia.

Journal: Advances in therapy
Published: June 02, 2026

Changes in Hospitalization and Infection Burden in Patients with Multiple Myeloma Before and During the COVID-19 Pandemic.

Changes in Hospitalization and Infection Burden in Patients with Multiple Myeloma Before and During the COVID-19 Pandemic.

Journal: Journal of clinical medicine
Published: May 07, 2026

MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

Journal: Blood
Published: March 02, 2026

Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing.

Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing.

Journal: HemaSphere
Published: December 23, 2025

Prognostic value of interim PET-CT in follicular lymphoma.

Prognostic value of interim PET-CT in follicular lymphoma.

Journal: Medicina clinica
Published: September 24, 2025

Immune biomarkers of increased infection risk in multiple myeloma.

Immune biomarkers of increased infection risk in multiple myeloma.

Journal: Blood
Published: September 22, 2025

Immune biomarkers of increased infection risk in multiple myeloma.

Immune biomarkers of increased infection risk in multiple myeloma.

Journal: Blood
Published: September 22, 2025

A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometry.

A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometry.

Journal: HemaSphere
Published: August 21, 2025

Combining an immunomodulatory drug with a TPO-RA to treat multirefractory ITP patients: The Spanish ITP Group experience.

Combining an immunomodulatory drug with a TPO-RA to treat multirefractory ITP patients: The Spanish ITP Group experience.

Journal: British journal of haematology
Published: June 18, 2025

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment.

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment.

Journal: Blood
Published: March 14, 2025

Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial.

Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial.

Journal: The Lancet. Haematology
Published: January 22, 2025

Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry.

Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry.

Journal: HemaSphere
Published: November 10, 2024
Showing 1-12 of 32

Last Updated: 09/26/2026